-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Stem Cell Transplantation for ALL: You’ve Always Got a Donor, Why Not Always Use It?

Program: Education Program
Session: CAR T Cells in ALL: Bridge or Definitive Therapy?
Hematology Disease Topics & Pathways:
Lymphoid Leukemias, ALL, Combination therapy, Diseases, Therapies, Lymphoid Malignancies
Saturday, December 9, 2023, 9:30 AM-10:45 AM

Alice Bertaina, MD, PhD

Stanford University, Palo Alto, CA

Disclosures: Bertaina: Miltenyi: Honoraria; Neovii: Honoraria; CellevolveBio: Membership on an entity's Board of Directors or advisory committees; AdicetBio: Membership on an entity's Board of Directors or advisory committees; Gilead: Research Funding.

See more of: CAR T Cells in ALL: Bridge or Definitive Therapy?
See more of: Education Program
<< Previous Presentation | Next Presentation >>